Entity

Time filter

Source Type


Grant
Agency: Cordis | Branch: FP7 | Program: CSA | Phase: ICT-2007.9.1 | Award Amount: 1.01M | Year: 2007

IST-Africa (2008 - 2009) is a collaborative Initiative between 2 European and 7 African partners, government agencies responsible for ICT adoption and SandT research policy in 6 African ACP Countries (Botswana, Lesotho, Mozambique, Namibia, Tanzania, Uganda), and a FP7 National Contact Point (NCP) for South Africa. Main objectives are: - To open up the ERA to Africa, identify ICT activities, common needs and opportunities for ICT research collaboration between Europe and Africa; - To promote research cooperation between European and African organizations under FP7-ICT, and promote the inclusion of African partners in proposals addressing: Challenge 1: Pervasive and Trusted Network and Service Infrastructures Challenge 4: Digital Libraries and Content Challenge 5: Towards sustainable and personalised healthcare Challenge 6: ICT for Mobility, Environmental Sustainability and Energy Efficiency Challenge 7: ICT for Independent Living and Inclusion - Investigate regulation and its role in ICT take-up and usage in relation to areas such as mobile communication, broadband, accessibility and security - Analyse the RTD policy approach of developing and developed nations to provide valuable knowledge and inform Information Society related decisions at a policy level - To deliver 28 FP7 Training Workshops in IST-Africa Partner Countries to raise awareness of opportunities to participate in the FP7 ICT Research Theme, provide insight into open calls, and provide necessary support to interested organizations - To deliver 2 international research conferences in Africa (300\ delegates) to facilitate European-African networking, and highlight opportunities for research collaboration - To deliver 4 European IST-Africa Workshops, focused on raising awareness of collaboration opportunities and supporting Policy Dialogues with Africa


Grant
Agency: Cordis | Branch: FP7 | Program: CSA-CA | Phase: INCO-2007-1.5 | Award Amount: 4.92M | Year: 2008

The CAAST-Net project will establish a platform to promote improved cooperation in science and technology between Europe and Sub-Saharan Africa. To achieve this objective, CAAST-Net will analyse the current European and African S&T cooperation landscape, and undertake S&T policy analyses. Informed by the outcomes of analyses, CAAST-Net will initiate and support European-African S&T policy dialogues to advance cooperation and broker partnerships. CAAST-Net outcomes will include identification of specific research topics for European-African cooperation and their recommendation for inclusion in FP7. CAAST-Net will promote African participation in the FP7 as well as greater synergy between S&T partnerships and development cooperation instruments. Implemented by a consortium of leading European and African agencies mandated by their governments to promote international S&T cooperation, CAAST-Net will be a key instrument to support the implementation of the overall S&T cooperation programmes agreed to by the mandated authorities of the EU and the African Union (AU). CAAST-Net has been developed with the support of the AU and NEPAD. CAAST-Net has 7 Work Packages: WP1 will gather and analyse information on current European-African S&T collaboration and on S&T policies and capacities which determine opportunities for future cooperation. WP2 considers the synergy between S&T partnerships and development cooperation instruments. The S&T policy dialogue platform under WP3 will promote European-African S&T policy discussions on themes identified in WP1 to frame an enabling policy environment for S&T cooperation. WP4 will establish S&T cooperation platforms to actively promote European-African S&T partnerships, especially for SICAs under FP7. WP5 will focus on improving FP7 information and advisory capacities available to African researchers via NCPs. The focus of WP6 is knowledge management and outreach, and WP7 is dedicated to ensuring efficient project management.


Olszewski W.L.,Polish Academy of Sciences | Olszewski W.L.,Japanese Ministry of Internal Affairs and Communications Japan
International Angiology | Year: 2011

The microsurgical lympho-venous shunts have become one of the generally accepted modalities in treatment of limb lymphedema. This review highlight the indications for this procedure after over 40 years. This study was based on the personal experience of one surgeon and on the review of the literature. Patients with postinflammatory, postsurgical, idiopathic and hyperplastic lymphedema of lower limbs were included in the study. Basing on the review of results of the last 40 years the contemporary indications are: 1) lymphedema with local segmental obstruction but still partly patent distal lymphatics seen on functional lymphoscintigraphy (standard walking or pneumatic compression) and without an active inflammatory process in the skin, subcutaneous tissue and lymph vessels (DLA-dermatolymphangioadenitis); 2) classified according the etiology of lymphedema, this operation can bring about satisfactory results in cases of hyperplastic, postsurgical and postinflammatory types of lymphedema, whereas primary idiopathic lymphedema of non-genetic type should be treated with conservative means, although in a small number of cases an improvement was observed after lympho-venous shunting as long as 10 years. Microsurgical lymph node or lymphatic vessel to vein shunts have their established position among the therapy modalities for lymphedema of lower limbs in a strictly defined group of patients using lymphoscintigraphic imaging. Source


Olszewski W.L.,Polish Academy of Sciences | Olszewski W.L.,Japanese Ministry of Internal Affairs and Communications Japan
Phlebologie | Year: 2012

The author presents the actual definition of the lymphatic system, how close and dependent it is on the venous system, what is its composition, how does tissue fluid and lymph flow between the cells to the blood circulation, how it is changed in lymphedema, and in particular what is the tissue fluid/ lymph biochemistry, pressure and flow, histopathology and tissue location, and finally how to manage the most common complication of lymphedema that is dermato-lymphangioadenitis. © Schattauer 2012. Source


Hagihara A.,Kyushu University | Hasegawa M.,Japanese Ministry of Internal Affairs and Communications Japan | Abe T.,Kyushu University | Wakata Y.,Kyushu University | And 2 more authors.
PLoS Medicine | Year: 2013

Background: No studies have evaluated whether administering intravenous lactated Ringer's (LR) solution to patients with out-of-hospital cardiac arrest (OHCA) improves their outcomes, to our knowledge. Therefore, we examined the association between prehospital use of LR solution and patients' return of spontaneous circulation (ROSC), 1-month survival, and neurological or physical outcomes at 1 month after the event. Methods and Findings: We conducted a prospective, non-randomized, observational study using national data of all patients with OHCA from 2005 through 2009 in Japan. We performed a propensity analysis and examined the association between prehospital use of LR solution and short- and long-term survival. The study patients were ≥18 years of age, had an OHCA before arrival of EMS personnel, were treated by EMS personnel, and were then transported to hospitals. A total of 531,854 patients with OHCA met the inclusion criteria. Among propensity-matched patients, compared with those who did not receive pre-hospital intravenous fluids, prehospital use of LR solution was associated with an increased likelihood of ROSC before hospital arrival (odds ratio [OR] adjusted for all covariates [95% CI] = 1.239 [1.146-1.339] [p<0.001], but with a reduced likelihood of 1-month survival with minimal neurological or physical impairment (cerebral performance category 1 or 2, OR adjusted for all covariates [95% CI] = 0.764 [0.589-0.992] [p = 0.04]; and overall performance category 1 or 2, OR adjusted for all covariates [95% CI] = 0.746 [0.573-0.971] [p = 0.03]). There was no association between prehospital use of LR solution and 1-month survival (OR adjusted for all covariates [95% CI] = 0.960 [0.854-1.078]). Conclusion: In Japanese patients experiencing OHCA, the prehospital use of LR solution was independently associated with a decreased likelihood of a good functional outcome 1 month after the event, but with an increased likelihood of ROSC before hospital arrival. Prehospital use of LR solution was not associated with 1-month survival. Further study is necessary to verify these findings. Please see later in the article for the Editors' Summary. © 2013 Hagihara et al. Source

Discover hidden collaborations